it's even posted on their website they have the ability to do so


as for the person mocking me via PM, all you do is enable the company to keep quiet when things don't go Leo's way. GLTA

All IPIX has to do is announce the date the IND was submitted to the FDA

There is no way (that I am aware of) to check if indeed there was a pre-IND or CTA just like the many different variations of grant news we heard about over the last several months.

Had IPIX PR'd both the CTA and IND had been submitted I would not have changed my tune over the last few days. What was the rush to PR the unnamed overseas CTA before the IND? It's just very odd

How about we apply that same logic to the grants. I see why people don't trust management. I would like to believe but there is a pattern over thr years of not building investor confidence. I am stuck. Can only hope for a miracle between now and year end. Cmon ipix. I tried patience and u showed me ur true colors.

IPIX CEO needs to grow a conscience

his reluctance of updating investors in a timely fashion, or even answering basic investor questions, is a poor pubco quality

He is a master at keeping hope alive. He hooked this sucker.

I think it was a big hit to his ego when the grant failed even though we were tied at the hip to a US government RBL collaborator. Yes, yes, now the data wasn't strong enough is the excuse. Well, we have better info for weeks now, even months depending upon which information one wants to use, to apply for a new grant.

I felt way back when this ceo was a deer in headlights. The nefarious crew on here are only bringing to light this poor ceo quality.

what would make me be quiet? post an update to the website that the IND was submitted. where was the cta submitted? what is the dosing schedule? when are interim results? any of you thinking i am asking for too much are in denial. Just like the company pushing the grant stuff for weeks and weeks via pr, we are now at a precipice. Was the IND actually submitted last week? If the CEO, who is also the IR person, would answer that basic question in writing, i think it would go a long way.

i don't mind being ignored... The IPIX CEO got me used to it

Also there are hundreds of other therapeutics out there for BP to sweep under the rug. Why is IPIX so special?

And for those who think that IPIX had to release the PR last week before the IND was submitted because of the PFE and Moderna vaccines, what about the Regeneron news today? FInd a new excuse... seems to be what Leo is good at attracting. Defending a poor CEO quality. Just being honest.

the fda website clearly says they do not approve an ind. the goal of the sponsor is not to get delayed during the 30 day wait period after the ind is submitted to the fda.

why issue a pr before the ind and not just wait a few more days to say both the ind and overseas cta were submitted? makes no sense. now the excuse this week will be it's a holiday week and why waste the pr. this company needs an investor relations firm asap

Did I miss the IND actually being submitted PR? I can only find the pr saying a CTA was submitted to one of 194 possible countries and that the IND should be submitted by end of week. Seems like a pretty big milestone not to PR.

BM's still trending up

currently 946

surprising since we were around .21 - .23 when we had 933 BM

It's either dilution or shorting or both.... can there be 3 ors?

based on the pr's, i believe the cro and cdmo are set up

i don't 100% believe there are hospitals knocking down our door to get Brilacidin

There has been much support from the bulls here from the get go, but even with GMU attached to B, we couldn't get a grant for in vivo studies. that is scary

wall st, no, ipix is proving to be another expensive lesson.... when will i learn

if there is nothing to hide, name the cro, cdmo, where the cta was submitted, if the ind was submitted (unless leo doesn't want investors to know the 30 day countdown start date), who warren weston is, are our advisors academic advisors as noted in the 10Q or business advisors, what the course of action is, what the dosing is, when will interim results be ready, how many patients of the 120 will be overseas, how many patients will be in the us, did the new grant app go out.... always more questions then answers

i appreciate all the pm's i have received but seeing is believing.

Agreed. With that being said ipix needs to issue a pr stating the ind has been submitted on such and such date. We all saw ipix hide the unsuccessful grant news.... which is what people have been warning us about the ceo. Ipix prd multiple times about the grant in the works but hid when it didn't pan out as first thought and then had an excuse several months later instead of saying we failed but this is how we are going to proceed once they found out.

"upon gaining required approvals"

how many approvals does it take for IPIX to screw in a lightbulb?

Imho it's easier for a muddy waters, af, hindenburg, etc... to pick apart a company that has seen it's o/s go up rather than being direct with shareholders during this pandemic. the o/s has not been blown out of the water, but the increases are due to compensation and financing. the fear of being picked apart by a mako newsletter by being too upfront with investors is a poor excuse unless ipix wants to issue an investor update to this effect.

more questions then answers at each step of the way. i look forward to a more 'transparent' ipix over the next few weeks, but not holding my breath.

i can only use an example of the company making leronlimab. that pubco was punished too down to the pennies and rose like phoenix out of the ashes when they found out their lead candidate had positive covid19 benefits. the ceo was out in the forefront doing whatever he could to inform investors, a little bit too sales pitchy at times, but he didn't say BP is going to hold back this gem. Any time he could get up on a hilltop and shout at the top of his lung so everyone would pay attention to their candidate, he did so. He advised of milestones and even didn't hide if milestones did not hit but he always said 'this is how we are going to handle it.' even companies that were hired by them, like amarex, we're putting out their own press releases for greater coverage.

we don't get that here. IPIX took off to like a phoenix rising from the ashes, but then as more pr's started coming out re Brilacidin for Covid19, the pr's were getting more about hitting people's emotions vs telling us what's going on and the pps did a 180. IPIX is a pubco that feels as if it's not telling us all the fine print with each step it's taking for an investor to make an informed decision.

For anyone thinking of replying why don't you buy the other stock and sell this one, don't bother. i enjoy figuring out the enigma that ipix is. based on the preclinical data so far, brilacidin seems amazing. With the company claiming to have manufactured the drug for the Covid trial, IND to be submitted this week = mid Dec US human trials begin, CTA overseas already submitted.... why would i leave the party now?

it seems no matter here in the US or 'overseas,' we'll need to see the study listed here: https://clinicaltrials.gov/ct2/home

i guess it's only a matter of time till study #5 shows up... the big question is how much longer????? c'mon

because i enjoy trying to figure out ipix's cloak and dagger prs. cdmo not named, yet they announce they already manufactured enough B for this trial (and possible future trials). multiple cro's hired by ipix, but none named. this is all normal reg fd stuff, but there seems to be a mystery surrounding ipix's current venture. i asked for a clue and i do believe there to be credibility to it. for some reason, i thought the ireland biz license expired. not sure where i saw that or why i am coming to that conclusion. if i find something other then 'hunch' i will happily share it with the forum.

For those researching europe, this looks like a handy dd link

https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines-covid-19

Let me dig and see what concrete info I can find. If you are not seeing the same information as me on this forum, I would rather not lead you on a wild goose chase. I don't want to feel like the guy from 'a beautiful mind.'

i asked for info and someone kindly replied. things i will be looking for

that's why you hire a cro that specializes in overseas rules/regulations in that country

imho it will be proven sooner then later the overseas suspicion is correct

i have alluded to playing the ihub game previously. call it a hunch it's more then a wild guess overseas stands for russia. i assume we'd hear something around thanksgiving or the following week along these lines. who knows, biorasi might even be one of ipix's cro's. global hq in florida a stone's throw from boca raton with an office in moscow.

others are posting clues/suspicions

been down this road before

the nice thing about penny stocks is (if and) when they hit, the payout is big and quick. just have to endure lot's of bs and bagholding along the way

I think we should all have some Vodka at Thanksgiving dinner

sounds exciting. thanks for the update

if we are using biorasi as one of the cro's, it seems they have the process down pat to get us into human trials this month in russia

i am liking this biorasi

global HQ in Miami

looks like they have strealined the process down to 15 days according to this 1 trial they put together in Russia:
https://www.biorasi.com/case-studies/edc-irt-strategy

this has nothing to do with ipix - just background info on the above 15 day timeframe
https://www.biorasi.com/news/biorasi-begins-second-covid-19-clinical-trial-of-2020/

that would suggest possibly being able to dose first humans by end of Nov and get interim results by mid-December. i think i saw someone suggest this timeframe yesterday on here (or i am just making this stuff up)

I am just thinking out loud. Could be Russia. Could be China. I asked for a heads up from an ihubber and only 1 person replied with Russia so that is the lead i am following.

According to the new Law on Drugs, foreign sponsors
may apply for clinical trial authorization under two
circumstances:
1. As part of the registration process for a new drug in
Russia (marketing authorization) or,
2. As part of an international multi-country study (if is
the study is not conducted for purposes of registration
in Russia).

I assume IPIX would go with Option 2. I think someone picked up on the fact it doesn't specify which "multi-center" will be the first to enroll humans, or better yet, WHERE

Seems like if Russia is the place, and we can pinpoint this date:

OK, so let's assume Russia is where the CTA was submitted

The paper suggests having a local CRO " expertise of local regulatory experts to
ensure proper navigation through the regulatory process." Biorasi apparently is a CRO

Thank you

quick favor to ask - ihub has proven to have players that know more then the rest of us. if someone here who possibly knows which overseas venue it is, can you do a quick google search of that country and brilacidin or innovation pharmaceuticals to see if there is a hit on google and post it here as an "....oh boy, look at what i just found on google"

let's agree to disagree

actually I did agree with you because submitted could mean they submitted it at 8:59AM today and then issued a 9AM PR. That is not twisting in any, way shape or form.

everything here is cloak and dagger. it's part of the fun (not really)

let's see if the unnamed overseas country will put out a new release like gmu did to inform us ipix investors

"announces today that an overseas Clinical Trial Application (CTA) has been submitted to the governing health agency"

that could easily be interpreted either as "hey just letting you know we already submitted a cta" or "just to let you know today we submitted a cta with the ind on deck later this week"

i wish these pr's wouldn't leave me with more questions

1) was the CTA filed today or are they announcing today that they previously submitted a CTA overseas?

2) overseas? which country?

3) i am sure each country has adapted different sets of timelines for a cta approval. anyone have any info on various country timelines?

2 countries that come to mind are venezuela and russia.... venezuela has news about a therapeutic that inhibits covid and russia put out vaccine news 6 or 8 weeks ago that was highly dismissed. maybe china since ipix mentioned something about china back in february or march via pr. does a cta today mean overseas trial also starting this Q?

unless it's to combine remdesivir with brilacidin; that would generate a big pop as well as prophylactic inhaler (2 items noted in the preprint)

Good. Let him tell the investment community that a) cta done and b) ind this week

that would keep his word about being able to commence human trials Q42020

after thanksgiving, i am sure there will be fast trial enrollment with the upcoming spike in cases to never seen before numbers (unfortunately as i am not rooting for people to get sick)

looks like they are reapplying for new grants

The Company is collaborating with a Regional Biocontainment Laboratory (RBL) for federal grants to fund continued research on Brilacidin as a treatment for
SARS­CoV2. An earlier grant application was unsuccessful. At the time of that grant filing deadline, the only research data available was limited to non­human
Vero cells. Subsequent to the filing, human cell line experiments were completed and the data is now available. Additional grant applications incorporating the
new data are planned for submission before the end of 2020.

10Q showing 7.2 million cash

10Q out also
http://www.ipharminc.com/financials

NEWS

we are on page 307
http://bov.gmu.edu/wp-content/uploads/Meeting-book-Full-Board-Meeting-October-1-2020-Updated-9.28.20.pdf

oooops. you are right. that's what i get for looking at this stock over the weekend

if you look up george mason kyle weston you will see he's a student that majors in biology and an athlete. so the zoom link managed to connect this weston to ipix before the GMU article came out

as for the other weston, it just seems like an odd coincidence that a gmu student wrote GMU press release and then we have a second weston listed on the pre-print as a consultant to ipix

hopefully at least warren weston will be clarified in the upcoming quarterly report

could just be a coincidence that 2 unrelated westons surface at the same time

it's funny there is another weston listed on this GMU article

you can link back to the post i am replying to for the other 'weston'



PREVIOUS ZOOM INFO POSTED - who are the Westons?
https://www.zoominfo.com/pic/innovation-pharmaceuticals-inc/409371534